A phase I study of an oral formulation of ixabepilone (ixa) in patients with advanced cancer He, A. R., Kunz, P. L., Pishvaian, M. J., Colevas, A. D., Hwang, J. J., Clemens, P. L., Messina, M., Kaleta, R., Abrahao, F., Sikic, B. I. AMER SOC CLINICAL ONCOLOGY. 2010

View details for DOI 10.1200/jco.2010.28.15_suppl.e13090

View details for Web of Science ID 000208852000315